Prelude Therapeutics Inc (PRLD) USD0.0001
2.05%- This stock can be held in a
Stocks and Shares ISASell:$3.35
Buy:$4.10
Change:
$0.28 (8.14%)
$0.28 (8.14%)Market closed | Prices delayed by at least 15 minutes
Sell:$3.35
Buy:$4.10
Change:$0.28 (8.14%)
$0.28 (8.14%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 4 April 2024 | Jane Edna HuangPresident | Sell Tax related | 3,347 | $4.74 | $15,864.78 | 51,287 |
| 4 January 2024 | Jane Edna HuangPresident | Sell Tax related | 3,844 | $3.77 | $14,491.88 | 45,259 |
| 13 December 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 7,343,307 | $3.15 | $23,130,682.72 | 17,968,343 |
| 13 December 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 593,452 | $3.15 | $1,869,314.45 | 1,563,672 |
| 4 July 2023 | Jane Edna HuangPresident | Sell Tax related | 3,242 | $4.65 | $15,075.30 | 30,353 |
| 25 May 2023 | Krishna (Kris) VaddiCEO | Buy Regular purchase transaction | 900 | $5.31 | $4,779.00 | 1,067,275 |
| 24 May 2023 | Krishna (Kris) VaddiCEO | Buy Regular purchase transaction | 1,000 | $5.01 | $5,011.40 | 1,066,375 |
| 24 May 2023 | Bryant David LimChief Legal/Compliance Officer | Buy Regular purchase transaction | 2,400 | $5.39 | $12,936.00 | 2,400 |
| 23 May 2023 | Krishna (Kris) VaddiCEO | Buy Regular purchase transaction | 11,856 | $5.63 | $66,749.28 | 1,065,375 |
| 23 May 2023 | Laurent ChardonnetCFO | Buy Regular purchase transaction | 5,000 | $5.50 | $27,500.00 | 42,165 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 22 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 10,625,036 | $5.75 | $61,092,894.50 | 10,625,036 |
| 13 December 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 7,343,307 | $3.15 | $23,130,682.72 | 17,968,343 |
| 22 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 1,327,044 | $5.75 | $7,630,503.00 | 6,539,415 |
| 22 May 2023 | BAKER BROS ADVISORS LPHedge Fund | Buy Regular purchase transaction | 970,220 | $5.75 | $5,578,667.98 | 970,220 |
| 22 May 2023 | ORBIMED ADVISORS LLCPrivate Equity | Buy Regular purchase transaction | 869,565 | $5.75 | $4,999,998.75 | 10,119,756 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.